Autoantibodies Specific for the Phospholipase A2 Receptor in Recurrent and De Novo Membranous Nephropathy
Open Access
- 9 August 2011
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 11 (10), 2144-2152
- https://doi.org/10.1111/j.1600-6143.2011.03643.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- De novo membranous nephropathy and antibody‐mediated rejection in transplanted kidneyClinical Transplantation, 2011
- A Case of Phospholipase A2 Receptor–Positive Membranous Nephropathy Preceding Sarcoid-Associated Granulomatous Tubulointerstitial NephritisAmerican Journal of Kidney Diseases, 2011
- Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in TaiwanJournal of Biomedical Science, 2010
- Beneficial Effect of Rituximab in the Treatment of Recurrent Idiopathic Membranous Nephropathy after Kidney TransplantationClinical Journal of the American Society of Nephrology, 2010
- Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2Journal of the American Society of Nephrology, 2010
- Recurrent Idiopathic Membranous Nephropathy: Early Diagnosis by Protocol Biopsies and Treatment with Anti-CD20 Monoclonal AntibodiesAmerican Journal of Transplantation, 2009
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- De novo membranous nephropathy associated with donor‐specific alloantibodyClinical Transplantation, 2007
- Treatment of de novo and recurrent membranous nephropathy in renal transplant patientsSeminars in Nephrology, 2003
- IMPACT OF DE NOVO MEMBRANOUS GLOMERULONEPHRITIS ON THE CLINICAL COURSE AFTER KIDNEY TRANSPLANTATIONTransplantation, 1994